ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,139, issued on Sept. 30, was assigned to Shanghai Jiao Tong University (Shanghai).
"Applications for nicardipine in preparing anti-lung cancer products" was invented by Yongyong Shi (Shanghai) and Zhijian Song (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention discloses uses for nicardipine in preparing anti-lung cancer products. This invention provides uses for nicardipine in the preparation of products to treat non-small cell lung cancer. From carrying out cancer drug repositioning for the FDA- and CFDA-approved drug nicardipine, experiments for this invention show, based on screening of non-anti-cancer drugs for various canc...